# Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness

> **NCT02896920** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 165 (actual)

## Conditions studied

- Hidradenitis Suppurativa (HS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02896920
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-20
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-04-29
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896920, "Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02896920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*